Company Exalenz Bioscience Ltd. TEL AVIV STOCK EXCHANGE
Equities
IL0011048688
Medical Equipment, Supplies & Distribution
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 10-09-30 |
Moshe Dori
DFI | Director of Finance/CFO | - | 19-01-28 |
Eitan Blank
COO | Chief Operating Officer | 54 | 06-12-31 |
Ofer Schlesinger
CTO | Chief Tech/Sci/R&D Officer | 59 | 14-07-22 |
Ilan Ben Oren
CTO | Chief Tech/Sci/R&D Officer | 59 | 06-04-10 |
Didier Samuel
PRN | Corporate Officer/Principal | - | - |
Ari Soae
PRN | Corporate Officer/Principal | 46 | 05-12-31 |
Ilan Haikin
AUD | Comptroller/Controller/Auditor | 69 | 10-11-20 |
Gavin Doree
SAM | Sales & Marketing | 47 | 13-07-28 |
Susan Alpert
LAW | General Counsel | 78 | 10-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 16-07-03 |
Moshe Arkin
BRD | Director/Board Member | 69 | 05-12-31 |
Hanna Lerman
BRD | Director/Board Member | 51 | 15-04-15 |
Itai Arkin
BRD | Director/Board Member | 35 | 15-04-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,917,095 | 6,557,013 ( 24.36 %) | 0 | 24.36 % |
Company contact information
Meridian Bioscience Israel Ltd.
4 Ha'maayan Street
7177872, Modi'in-Maccabim-Re'ut
+
Sector
1st Jan change | Capi. | |
---|---|---|
-5.43% | 182B | |
+4.30% | 114B | |
-3.09% | 68.38B | |
+5.86% | 52.46B | |
+8.15% | 44.25B | |
+7.52% | 43.55B | |
+25.54% | 32.69B | |
+17.85% | 26.73B | |
+1.00% | 25.79B |